Dr. Michael Charles Madigan, MD

Dr. Madigan practices at UPMC Passavant-McCandless in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Madigan's NPI, 1164669362, was assigned on January 10, 2009. Dr. Madigan graduated from Vanderbilt University School of Medicine in 2007. Dr. Madigan holds Pennsylvania license MD439476.

Dr. Madigan's primary practice is UPMC Passavant-McCandless, at 9100 Babcock Boulevard, Pittsburgh, PA 15237 in Allegheny County. The practice phone is (412) 367-6700.

Dr. Madigan's primary practice is UPMC Passavant-McCandless in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Madigan is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Madigan to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Madigan practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Madigan's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Madigan is licensed in Pennsylvania.

CMS data shows 724 Medicare services from Dr. Madigan across 15 procedure codes in 2024, for 573 Medicare patients. Medicare paid $38,648 for them.

CMS counts 573 Medicare patients who saw Dr. Madigan in 2024. The largest group is 65 to 74, with 242 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Madigan's median patient age at 74, with 39% women.

In 2024, Dr. Madigan wrote 251 Medicare Part D claims for 94 patients. 86% of them were for generic drugs. CMS names the drug for 197 of them, across 6 drugs with 11 or more claims each, at $41,310 in total drug cost. In 2023, CMS named 130 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Madigan for performance year 2024, reported as part of a group. Dr. Madigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of leg revascularization (restoring blood flow) by Dr. Madigan, more than 70% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 40 general payments to Dr. Madigan from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. W. L. Gore & Associates, Inc. paid the most, $927.

Dr. Madigan graduated from Vanderbilt University School of Medicine in 2007.